Proud to come here to BioStars to announce that we're offering 30x whole genome sequencing for $3,490! This seems like the kind of place where like minded people have also really, really, really wanted to get their own genome sequenced. Well, at least me and my founder have really wanted to do it. Recode just ran a story on us!
Personal genome sequencing can be framed in terms of "helping science" or "learning about yourself" but it is undeniable that the vast majority of the information related to genomes target human health and other related information. So it may be immaterial how one labels the product if it can mostly be used in one way.
It is a bit like selling a product with implications for health that have not been actually verified. There are plenty of such products and it seems the only requirement is to label them as "This product has not be approved by FDA". I wonder if any or all genome sequences or analyses should be labeled as such and if that would in fact satisfy regulatory bodies. These are uncharted waters.
After all just as Uber disrupts a heavily regulated taxi industry would it be possible that a bioinformaticians could disrupt medical industry? Or that an answer on Biostars on interpreting data could be constructed as essential component of a diagnosis? Stranger things have happened.
On Genohub I already see 2 packages offering 35x coverage on HiSeqX10 for $1800 (1 commercial in Seoul, one academic in Australia). I think with the rollout of the X10 in 1/2 a year it should not be a problem finding similar packages reliably. (Maybe these 2 now might be just to fill low capacity). And with bulk it should be even easier to find labs with a package at this price.